Data as of Aug 29
| +0.35 / +0.64%|
The 17 analysts offering 12-month price forecasts for Metlife Inc have a median target of 63.00, with a high estimate of 67.00 and a low estimate of 58.00. The median estimate represents a +15.09% increase from the last price of 54.74.
The current consensus among 22 polled investment analysts is to Buy stock in Metlife Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.